Cargando…

Reproducibility of 3D MRSI for imaging human brain glucose metabolism using direct ((2)H) and indirect ((1)H) detection of deuterium labeled compounds at 7T and clinical 3T

INTRODUCTION: Deuterium metabolic imaging (DMI) and quantitative exchange label turnover (QELT) are novel MR spectroscopy techniques for non-invasive imaging of human brain glucose and neurotransmitter metabolism with high clinical potential. Following oral or intravenous administration of non-ioniz...

Descripción completa

Detalles Bibliográficos
Autores principales: Niess, Fabian, Strasser, Bernhard, Hingerl, Lukas, Niess, Eva, Motyka, Stanislav, Hangel, Gilbert, Krššák, Martin, Gruber, Stephan, Spurny-Dworak, Benjamin, Trattnig, Siegfried, Scherer, Thomas, Lanzenberger, Rupert, Bogner, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153308/
https://www.ncbi.nlm.nih.gov/pubmed/37131634
http://dx.doi.org/10.1101/2023.04.17.23288672
_version_ 1785035905482883072
author Niess, Fabian
Strasser, Bernhard
Hingerl, Lukas
Niess, Eva
Motyka, Stanislav
Hangel, Gilbert
Krššák, Martin
Gruber, Stephan
Spurny-Dworak, Benjamin
Trattnig, Siegfried
Scherer, Thomas
Lanzenberger, Rupert
Bogner, Wolfgang
author_facet Niess, Fabian
Strasser, Bernhard
Hingerl, Lukas
Niess, Eva
Motyka, Stanislav
Hangel, Gilbert
Krššák, Martin
Gruber, Stephan
Spurny-Dworak, Benjamin
Trattnig, Siegfried
Scherer, Thomas
Lanzenberger, Rupert
Bogner, Wolfgang
author_sort Niess, Fabian
collection PubMed
description INTRODUCTION: Deuterium metabolic imaging (DMI) and quantitative exchange label turnover (QELT) are novel MR spectroscopy techniques for non-invasive imaging of human brain glucose and neurotransmitter metabolism with high clinical potential. Following oral or intravenous administration of non-ionizing [6,6’-(2)H(2)]-glucose, its uptake and synthesis of downstream metabolites can be mapped via direct or indirect detection of deuterium resonances using (2)H MRSI (DMI) and (1)H MRSI (QELT), respectively. The purpose of this study was to compare the dynamics of spatially resolved brain glucose metabolism, i.e., estimated concentration enrichment of deuterium labeled Glx (glutamate+glutamine) and Glc (glucose) acquired repeatedly in the same cohort of subjects using DMI at 7T and QELT at clinical 3T. METHODS: Five volunteers (4m/1f) were scanned in repeated sessions for 60 min after overnight fasting and 0.8g/kg oral [6,6’-(2)H(2)]-glucose administration using time-resolved 3D (2)H FID-MRSI with elliptical phase encoding at 7T and 3D (1)H FID-MRSI with a non-Cartesian concentric ring trajectory readout at clinical 3T. RESULTS: One hour after oral tracer administration regionally averaged deuterium labeled Glx(4) concentrations and the dynamics were not significantly different over all participants between 7T (2)H DMI and 3T (1)H QELT data for GM (1.29±0.15 vs. 1.38±0.26 mM, p=0.65 & 21±3 vs. 26±3 μM/min, p=0.22) and WM (1.10±0.13 vs. 0.91±0.24 mM, p=0.34 & 19±2 vs. 17±3 μM/min, p=0.48). Also, the observed time constants of dynamic Glc(6) data in GM (24±14 vs. 19±7 min, p=0.65) and WM (28±19 vs. 18±9 min, p=0.43) dominated regions showed no significant differences. Between individual (2)H and (1)H data points a weak to moderate negative correlation was observed for Glx(4) concentrations in GM (r=−0.52, p<0.001), and WM (r=−0.3, p<0.001) dominated regions, while a strong negative correlation was observed for Glc(6) data GM (r=−61, p<0.001) and WM (r=−0.70, p<0.001). CONCLUSION: This study demonstrates that indirect detection of deuterium labeled compounds using (1)H QELT MRSI at widely available clinical 3T without additional hardware is able to reproduce absolute concentration estimates of downstream glucose metabolites and the dynamics of glucose uptake compared to (2)H DMI data acquired at 7T. This suggests significant potential for widespread application in clinical settings especially in environments with limited access to ultra-high field scanners and dedicated RF hardware.
format Online
Article
Text
id pubmed-10153308
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-101533082023-05-03 Reproducibility of 3D MRSI for imaging human brain glucose metabolism using direct ((2)H) and indirect ((1)H) detection of deuterium labeled compounds at 7T and clinical 3T Niess, Fabian Strasser, Bernhard Hingerl, Lukas Niess, Eva Motyka, Stanislav Hangel, Gilbert Krššák, Martin Gruber, Stephan Spurny-Dworak, Benjamin Trattnig, Siegfried Scherer, Thomas Lanzenberger, Rupert Bogner, Wolfgang medRxiv Article INTRODUCTION: Deuterium metabolic imaging (DMI) and quantitative exchange label turnover (QELT) are novel MR spectroscopy techniques for non-invasive imaging of human brain glucose and neurotransmitter metabolism with high clinical potential. Following oral or intravenous administration of non-ionizing [6,6’-(2)H(2)]-glucose, its uptake and synthesis of downstream metabolites can be mapped via direct or indirect detection of deuterium resonances using (2)H MRSI (DMI) and (1)H MRSI (QELT), respectively. The purpose of this study was to compare the dynamics of spatially resolved brain glucose metabolism, i.e., estimated concentration enrichment of deuterium labeled Glx (glutamate+glutamine) and Glc (glucose) acquired repeatedly in the same cohort of subjects using DMI at 7T and QELT at clinical 3T. METHODS: Five volunteers (4m/1f) were scanned in repeated sessions for 60 min after overnight fasting and 0.8g/kg oral [6,6’-(2)H(2)]-glucose administration using time-resolved 3D (2)H FID-MRSI with elliptical phase encoding at 7T and 3D (1)H FID-MRSI with a non-Cartesian concentric ring trajectory readout at clinical 3T. RESULTS: One hour after oral tracer administration regionally averaged deuterium labeled Glx(4) concentrations and the dynamics were not significantly different over all participants between 7T (2)H DMI and 3T (1)H QELT data for GM (1.29±0.15 vs. 1.38±0.26 mM, p=0.65 & 21±3 vs. 26±3 μM/min, p=0.22) and WM (1.10±0.13 vs. 0.91±0.24 mM, p=0.34 & 19±2 vs. 17±3 μM/min, p=0.48). Also, the observed time constants of dynamic Glc(6) data in GM (24±14 vs. 19±7 min, p=0.65) and WM (28±19 vs. 18±9 min, p=0.43) dominated regions showed no significant differences. Between individual (2)H and (1)H data points a weak to moderate negative correlation was observed for Glx(4) concentrations in GM (r=−0.52, p<0.001), and WM (r=−0.3, p<0.001) dominated regions, while a strong negative correlation was observed for Glc(6) data GM (r=−61, p<0.001) and WM (r=−0.70, p<0.001). CONCLUSION: This study demonstrates that indirect detection of deuterium labeled compounds using (1)H QELT MRSI at widely available clinical 3T without additional hardware is able to reproduce absolute concentration estimates of downstream glucose metabolites and the dynamics of glucose uptake compared to (2)H DMI data acquired at 7T. This suggests significant potential for widespread application in clinical settings especially in environments with limited access to ultra-high field scanners and dedicated RF hardware. Cold Spring Harbor Laboratory 2023-04-17 /pmc/articles/PMC10153308/ /pubmed/37131634 http://dx.doi.org/10.1101/2023.04.17.23288672 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Niess, Fabian
Strasser, Bernhard
Hingerl, Lukas
Niess, Eva
Motyka, Stanislav
Hangel, Gilbert
Krššák, Martin
Gruber, Stephan
Spurny-Dworak, Benjamin
Trattnig, Siegfried
Scherer, Thomas
Lanzenberger, Rupert
Bogner, Wolfgang
Reproducibility of 3D MRSI for imaging human brain glucose metabolism using direct ((2)H) and indirect ((1)H) detection of deuterium labeled compounds at 7T and clinical 3T
title Reproducibility of 3D MRSI for imaging human brain glucose metabolism using direct ((2)H) and indirect ((1)H) detection of deuterium labeled compounds at 7T and clinical 3T
title_full Reproducibility of 3D MRSI for imaging human brain glucose metabolism using direct ((2)H) and indirect ((1)H) detection of deuterium labeled compounds at 7T and clinical 3T
title_fullStr Reproducibility of 3D MRSI for imaging human brain glucose metabolism using direct ((2)H) and indirect ((1)H) detection of deuterium labeled compounds at 7T and clinical 3T
title_full_unstemmed Reproducibility of 3D MRSI for imaging human brain glucose metabolism using direct ((2)H) and indirect ((1)H) detection of deuterium labeled compounds at 7T and clinical 3T
title_short Reproducibility of 3D MRSI for imaging human brain glucose metabolism using direct ((2)H) and indirect ((1)H) detection of deuterium labeled compounds at 7T and clinical 3T
title_sort reproducibility of 3d mrsi for imaging human brain glucose metabolism using direct ((2)h) and indirect ((1)h) detection of deuterium labeled compounds at 7t and clinical 3t
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153308/
https://www.ncbi.nlm.nih.gov/pubmed/37131634
http://dx.doi.org/10.1101/2023.04.17.23288672
work_keys_str_mv AT niessfabian reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT strasserbernhard reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT hingerllukas reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT niesseva reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT motykastanislav reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT hangelgilbert reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT krssakmartin reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT gruberstephan reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT spurnydworakbenjamin reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT trattnigsiegfried reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT schererthomas reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT lanzenbergerrupert reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t
AT bognerwolfgang reproducibilityof3dmrsiforimaginghumanbrainglucosemetabolismusingdirect2handindirect1hdetectionofdeuteriumlabeledcompoundsat7tandclinical3t